VISIOMED GROUP (ALVMG.PA)
FR0013481835 - Common Stock
| TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -3.54M | -5.28M | -4.46M | -5.15M | -23.44M | |||
| Depreciation Amortization | 2.71M | 2.74M | N/A | N/A | 3.57M | |||
| Income Taxes - Deferred | 9.00K | 113.00K | 323.00K | N/A | 7.00K | |||
| Change In Working Capital | -1.96M | 838.00K | -3.18M | -3.56M | -1.42M | |||
| Other non cash items | -75.00K | -155.00K | 812.00K | -2.19M | -1.42M | |||
| OPERATING CASH FLOW | -2.86M | -1.74M | -6.50M | -10.90M | -22.71M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -4.98M | -5.51M | -196.00K | -245.00K | -56.00K | |||
| Other Investing Activity | 169.00K | -11.96M | -14.83M | 3.33M | 5.37M | |||
| INVESTING CASH FLOW | -4.82M | -17.47M | -15.02M | 3.08M | 5.31M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 7.78M | 11.52M | 25.29M | 0.00 | 6.35M | |||
| Stock Issued/Repurchased | N/A | N/A | N/A | N/A | N/A | |||
| Other Financing Activity | 9.00K | 3.25M | 1.94M | 1.74M | 17.30M | |||
| FINANCING CASH FLOW | 7.79M | 14.76M | 27.23M | 1.74M | 23.65M | |||
| Exchange Rate Effect | N/A | N/A | 62.00K | N/A | 0.00 | |||
| CHANGE IN CASH | 120.00K | -4.45M | 5.76M | -6.08M | 6.26M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -2.86M | -1.74M | -6.50M | -10.90M | -22.71M | |||
| Capital Expenditure | -4.98M | -5.51M | -196.00K | -245.00K | -56.00K | |||
| FREE CASH FLOW | -7.84M | -7.26M | -6.70M | -11.14M | -22.76M | |||
All data in EUR